|
Q4 FY2025
As of Dec 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
|
|---|---|---|---|---|---|---|---|
| Current assets | |||||||
| Cash and cash equivalents | |||||||
| Short-term investments | |||||||
| Accounts receivable, net | |||||||
| Advances to suppliers, net | |||||||
| Inventories, net | |||||||
| Loans receivable | |||||||
| Other receivable | |||||||
| Total other receivable | |||||||
| Prepaid expenses and other current assets | |||||||
| Total current assets | |||||||
| Non-current assets | |||||||
| Non-current accounts receivable, net | |||||||
| Non-current advance to a third party | |||||||
| Non-current loans receivable | |||||||
| Property, equipment and software, net | |||||||
| Long-term investments | |||||||
| Total non-current assets | |||||||
| Total Assets | |||||||
| Current liabilities | |||||||
| Accounts payable | |||||||
| Advances from customers | |||||||
| Advance from customers | |||||||
| Loan payable – related party | |||||||
| Related Party | |||||||
| Total loan payable – related party | |||||||
| Deferred revenue | |||||||
| Taxes payable | |||||||
| Accrued expenses and other current liabilities | |||||||
| Operating lease liabilities | |||||||
| Total current liabilities | |||||||
| Non-current Liabilities | |||||||
| Loan payable – related party | |||||||
| Related Party | |||||||
| Total loan payable – related party | |||||||
| Deferred income tax liabilities, net | |||||||
| Total non-current liabilities | |||||||
| Total Liabilities | |||||||
| Shareholders’ Equity | |||||||
| Ordinary shares value | |||||||
| Class A Ordinary Shares | |||||||
| Class B Ordinary Shares | |||||||
| Total ordinary shares value | |||||||
| Additional paid-in capital | |||||||
| Statutory reserve | |||||||
| Retained earnings | |||||||
| Accumulated other comprehensive loss | |||||||
| Total Shareholders’ Equity | |||||||
| Total Liabilities and Shareholders’ Equity | |||||||
Loading...